MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$34,478,226
EPS
-$0.59
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenue
-0 --
Research and development
27,376,912 23,132,671 20,359,098 22,047,254
General and administrative
9,395,941 6,023,337 5,924,942 5,671,880
Total operating expenses
36,772,853 29,156,008 26,284,040 27,719,134
Loss from operations
-36,772,853 -29,156,008 -26,284,040 -27,719,134
Other income
8,145 11,205 6,740 14,991
Investment income
2,904,506 2,021,214 1,713,499 1,793,352
Interest expense
-3,124,484.5* --
Gain on disposal of fixed assets
-81,143 78,759.5* -6,846 -
Total other income (expense)
2,831,508 -1,013,306 1,713,393 1,808,343
Loss before income taxes
-33,941,345 -30,170,514* --
(provision for) benefit from income taxes
-400* --
Net loss
-33,941,345 -30,170,914 -24,570,647 -25,910,791
Net unrealized gain (loss) on marketable securities
-536,881 -560,968 -543,452 -424,353
Comprehensive loss
-34,478,226 -30,731,882 -25,114,099 -26,335,144
Basic EPS
-0.59 -0.629 -0.54 -0.57
Diluted EPS
-0.59 -0.629 -0.54 -0.57
Basic Average Shares
57,434,267 48,851,809 45,716,151 45,709,071
Diluted Average Shares
57,434,267 48,851,809 45,716,151 45,709,071
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$34,478,226 (-46.05%↓ Y/Y)Net loss-$33,941,345 (-39.15%↓ Y/Y)Net unrealized gain(loss) on marketable...-$536,881 (-168.39%↓ Y/Y)Investment income$2,904,506 (298.13%↑ Y/Y)Other income$8,145 (-34.76%↓ Y/Y)Loss before incometaxes-$33,941,345 Total other income(expense)$2,831,508 (378.82%↑ Y/Y)Gain on disposal offixed assets-$81,143 (46.15%↑ Y/Y)Loss from operations-$36,772,853 (-47.19%↓ Y/Y)Total operatingexpenses$36,772,853 (47.19%↑ Y/Y)Research and development$27,376,912 (44.73%↑ Y/Y)General andadministrative$9,395,941 (54.86%↑ Y/Y)

CAPRICOR THERAPEUTICS, INC. (CAPR)

CAPRICOR THERAPEUTICS, INC. (CAPR)